Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Bristol Myers Squibb's sBLA Accepted by FDA for First-Line Treatment of Advanced Liver Cancer

Thursday, August 22, 2024

Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has accepted its supplemental Biologics License Application sBLA for the use of Opdivo nivolumab combined with Yervoy ipilimumab as a potential firstline treatment for ad...

University of Nottingham Enter into Partnership with Touchlight to Accelerate Zika Vaccine Development

Thursday, August 22, 2024

University of Nottingham are accelerating the development of a new DNA vaccine for the Zika virus thanks to a partnership with Touchlight a specialist in advanced DNA production University of Nottinghams goal is to create a Zika virus DNA vaccine tha...

Innovent’s Dupert® Gains NMPA Approval as China's First KRAS G12C Inhibitor

Thursday, August 22, 2024

Innovent Biologics has announced that Chinas National Medical Products Administration NMPA has approved Dupert fulzerasib for treating adult patients with advanced nonsmall cell lung cancer NSCLC who carry the KRAS GC mutation and have undergone at l...

Kelun-Biotech's TROP2-ADC sac-TMT Secures Second NDA for EGFR-Mutant NSCLC

Wednesday, August 21, 2024

KelunBiotech new drug application NDA for sacituzumab tirumotecan sacTMT formerly known as SKBMK has been accepted by the Center for Drug Evaluation CDE of the National Medical Products Administration NMPA in China

GSK Granted Breakthrough Therapy Designation by FDA for New Lung Cancer Treatment

Wednesday, August 21, 2024

GSK announced today that the US Food and Drug Administration FDA has awarded Breakthrough Therapy Designation to GSK GSK an investigational antibodydrug conjugate ADC targeting BH

China's NMPA Approved Astellas Pharma's PADCEV™ for Treating Locally Advanced or Metastatic Urothelial Cancer

Tuesday, August 20, 2024

Astellas Pharma has announced that Chinas National Medical Products Administration NMPA has approved PADCEV enfortumab vedotin for adult patients with locally advanced or metastatic urothelial cancer lamUC

PharmaDrug’s Sairiyo Approved for Phase 1 Trial of Reformulated Cepharanthine

Tuesday, August 20, 2024

PharmaDrug specialising in the research development and commercialisation of controlled substances and natural medicines including psychedelics and previously approved drugs announced on th August that Sairiyo Therapeutics Inc Which is owned by Pha...

CStone has received approval from China's NMPA for the manufacturing of AYVAKIT® (avapritinib tablets, 100 mg)

Monday, August 19, 2024

CStone Pharmaceuticals focused on developing innovative anticancer therapies has announced that the China National Medical Products Administration NMPA has approved

NSG BioLabs Enter into Collaborates with Merck to Boost Biotech Start-ups and Drive Innovation

Friday, August 16, 2024

NSG BioLabs has partnered with Merck to boost the research and development capabilities of NSG BioLabs tenants This collaboration aims to offer biotech startups access to vital resources and expertise facilitating opportunities for funding partnershi...

Chugai Pharmaceutical Submits Elevidys Gene Therapy for DMD in Japan

Friday, August 16, 2024

Chugai Pharmaceutical has submitted a regulatory application to Japans Ministry of Health Labour and Welfare MHLW for delandistrogene moxeparvovec a gene therapy currently in development also known as SRP with the overseas name Elevidys